
GHRP-2 Acetate
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
GHRP-2 Acetate is a synthetic growth-hormone-releasing peptide and a potent agonist of the ghrelin receptor. As a second-generation secretagogue, it drives strong GH release and is a widely used research reference in the GH-axis field.
| Test | Result | Status |
|---|---|---|
| Purity | 98.9% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 99.1% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 99.1% | Passed ✓ |
Research Information
GHRP-2 is studied for its strong stimulation of pituitary GH release and its effects on appetite-related signaling in laboratory models. It is frequently compared with GHRP-6 and hexarelin to characterize potency, selectivity and the degree of accompanying cortisol or prolactin release. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
GHRP-2 Acetate Research & Studies
What is GHRP-2 Acetate?
GHRP-2 Acetate is a synthetic hexapeptide classified as a growth-hormone-releasing peptide and a potent agonist of the ghrelin receptor (GHS-R1a). As a second-generation GH secretagogue, it is widely employed as a laboratory reference compound for examining pituitary GH release pathways. Research use centers on its defined structure and reproducible activity in controlled in-vitro and model-system settings. It is supplied strictly for non-clinical laboratory investigation.
Mechanism of Action
GHRP-2 Acetate binds and activates the growth hormone secretagogue receptor type 1a, the same receptor engaged by endogenous ghrelin. Receptor activation triggers intracellular signaling cascades that promote secretion of growth hormone from somatotroph cells in pituitary preparations. Parallel studies examine secondary effects on appetite-related neuropeptide circuits and modest co-release of other pituitary hormones under experimental conditions. These actions are characterized exclusively in isolated cells, tissue explants, and non-human laboratory models.
Primary Areas of Research
Investigators study GHRP-2 Acetate chiefly for its capacity to elicit robust GH release and to map ghrelin-receptor pharmacology. Comparative work places it alongside GHRP-6 and hexarelin to quantify relative potency, receptor selectivity, and the extent of concurrent cortisol or prolactin responses. Additional research explores its influence on appetite-signaling pathways and energy-balance markers in laboratory systems. All such work remains confined to in-vitro assays and controlled experimental models.
Key Research Findings
Laboratory data consistently show that GHRP-2 Acetate produces strong, dose-dependent stimulation of GH secretion via GHS-R1a activation. Comparative assays indicate higher GH-releasing potency relative to GHRP-6 in several pituitary models, with variable accompanying release of ACTH, cortisol, or prolactin depending on experimental design. Studies also document ghrelin-mimetic effects on orexigenic signaling circuits. These observations derive from cell-based and animal-model research and do not extend to clinical interpretation.
Research Handling & Considerations
GHRP-2 Acetate is intended solely for in-vitro and laboratory research applications and is not for human or animal consumption. Standard peptide-handling practices apply: protect from light and moisture, store under recommended cold conditions, and reconstitute with appropriate research-grade solvents. Investigators should verify identity and purity by analytical methods before use in experimental protocols. All work must comply with institutional biosafety and research-use guidelines.
Frequently Asked Questions
It acts as a selective agonist of the ghrelin receptor GHS-R1a, which mediates its effects on GH release pathways studied in pituitary and related laboratory systems.
Explore Other High-Purity Peptides

Ipamorelin

CJC-1295 (No DAC)

Sermorelin
